this is very funny. "accumulating"!!! "the exchange is telling him to shut up right now until they clear this hurdle." -- "the exchange" couldn't care less. what drivel.
someone would post negative info about the stock or the company here is to attempt to buy the stock soon at a lower price. it's that simple.
see the actual balance sheet to correct your distorted statement that cash is dwindling rapidly. it's not.
Notable Institutional Investors Adding Common Stock in Q1 (84.4% increase in aggregate shares held by institutions):
FMR added 18,008,732 shares to bring stake to 18,745,368 shares
First Eagle Investment Management added 3,636,300 shares to bring stake to 24,008,672
that four powerful, hi-volume buying days with price rising nearly 68% off low have been followed by a few lower volume consolidation days. those with patience (just a little) can add to their positions on days like today with a very favorable risk/reward picture. trolls here are to be enjoyed and ignored.
"At March 31, 2015, the Company had approximately $6.7 million of cash, cash equivalents, and investments in certificates of deposit, compared to $6.0 million at December 31, 2014. The increase in cash is due to more favorable operational results."
replace the first hour, subtract the lunch hour, multiply today's last hour by two, add the eye of a newt and there you have it!
Yes. e.g. Discovery Labs (DSCO). hired and built sales and distribution organization ... then "it" (regulatory approvals) didn't happen. into the toilet.
Isn't ADES an unlisted security? there are usually restrictions on mutual funds, for example, concerning the percentage of assets which can be invested in unlisted securities. In that sense, it's not only a matter of rebuilding trust with the market, it's a matter of even being _in_ the market. Finish the cleanup and get back into NASDAQ.
LOL. in the world of biotechs, there are few things more fundamental than the "delay".
they work for sleaze groups who want to ride coat-tails of First Eagle and FMR, etc.